Authors: DANNER SA CARR A LEONARD JM LEHMAN LM GUDIOL F GONZALES J RAVENTOS A RUBIO R BOUZA E PINTADO V AGUADO AG DELGADO R BORLEFFS JCC HSU A VALDES JM BOUCHER CAB COOPER DA

Citation: Sa. Danner et al., SAFETY, PHARMACOKINETICS, AND ANTIVIRAL ACTIVITY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 75-75

Authors: DANNER SA CARR A LEONARD JM LEHMAN LM GUDIOL F GONZALES J RAVENTOS A RUBIO R BOUZA E PINTADO V AGUADO AG DELOMAS JG DELGADO R BORLEFFS JCC HSU A VALDES JM BOUCHER CAB COOPER DA GIMENO C CLOTET B TOR J FERRER E MARTINEZ PL MORENO S ZANCADA G ALCAMI J NORIEGA AR PULIDO F GLASSMAN HN

Citation: Sa. Danner et al., A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE, The New England journal of medicine, 333(23), 1995, pp. 1528-1533